vs
Aligos Therapeutics, Inc.（ALGS）与法拉第未来（FFAI）财务数据对比。点击上方公司名可切换其他公司
Aligos Therapeutics, Inc.的季度营收约是法拉第未来的1.3倍（$169.0K vs $129.0K），法拉第未来同比增速更快（-45.1% vs -72.1%）
Aligos Therapeutics是一家临床阶段生物制药企业，专注于开发针对流行性肝病与病毒感染的新型靶向疗法，核心管线覆盖慢性乙型肝炎、非酒精性脂肪性肝炎等适应症，通过自主研发推进药物落地，满足全球未被满足的医疗需求。
法拉第未来是2014年成立的美国科技企业，总部位于加利福尼亚州洛杉矶，核心业务为研发电动汽车，2023年正式投入量产，产品在中美两国市场销售。截至2025年1月，该公司累计交付16辆汽车。2024年末完成两轮合计6000万美元融资后，法拉第未来宣布将转型销售贴牌中国厢式车。
ALGS vs FFAI — 直观对比
营收规模更大
ALGS
是对方的1.3倍
$129.0K
营收增速更快
FFAI
高出27.0%
-72.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $169.0K | $129.0K |
| 净利润 | — | $-33.6M |
| 毛利率 | — | -12111.6% |
| 营业利润率 | — | -25041.9% |
| 净利率 | — | -26011.6% |
| 营收同比 | -72.1% | -45.1% |
| 净利润同比 | 75.8% | 72.3% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALGSFFAI
| Q4 25 | $169.0K | $129.0K | ||
| Q3 25 | $741.0K | — | ||
| Q2 25 | $965.0K | — | ||
| Q1 25 | $311.0K | $316.0K | ||
| Q4 24 | $606.0K | $235.0K | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $1.1M | $293.0K | ||
| Q1 24 | $694.0K | — |
净利润ALGSFFAI
| Q4 25 | — | $-33.6M | ||
| Q3 25 | $-31.5M | — | ||
| Q2 25 | $-15.9M | — | ||
| Q1 25 | $43.1M | $-10.3M | ||
| Q4 24 | $-82.2M | $-121.3M | ||
| Q3 24 | $-19.3M | — | ||
| Q2 24 | $5.1M | $-108.7M | ||
| Q1 24 | $-34.9M | — |
毛利率ALGSFFAI
| Q4 25 | — | -12111.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6666.1% | ||
| Q4 24 | — | -8801.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -7057.0% | ||
| Q1 24 | — | — |
营业利润率ALGSFFAI
| Q4 25 | — | -25041.9% | ||
| Q3 25 | -3827.4% | — | ||
| Q2 25 | -1924.0% | — | ||
| Q1 25 | -6187.5% | -13870.6% | ||
| Q4 24 | -3393.2% | -12899.6% | ||
| Q3 24 | -1610.5% | — | ||
| Q2 24 | -2489.5% | -17272.7% | ||
| Q1 24 | -3176.7% | — |
净利率ALGSFFAI
| Q4 25 | — | -26011.6% | ||
| Q3 25 | -4256.0% | — | ||
| Q2 25 | -1643.8% | — | ||
| Q1 25 | 13854.7% | -3252.5% | ||
| Q4 24 | -13556.1% | -51599.6% | ||
| Q3 24 | -1540.7% | — | ||
| Q2 24 | 477.0% | -37093.9% | ||
| Q1 24 | -5023.5% | — |
每股收益（稀释后）ALGSFFAI
| Q4 25 | — | — | ||
| Q3 25 | $-3.04 | — | ||
| Q2 25 | $-1.53 | — | ||
| Q1 25 | $-2.11 | — | ||
| Q4 24 | $-13.10 | — | ||
| Q3 24 | $-3.07 | — | ||
| Q2 24 | $0.81 | — | ||
| Q1 24 | $-5.58 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.8M | $34.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $53.5M | $-27.3M |
| 总资产 | $88.5M | $277.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALGSFFAI
| Q4 25 | $77.8M | $34.9M | ||
| Q3 25 | $99.1M | — | ||
| Q2 25 | $122.9M | — | ||
| Q1 25 | $137.9M | $9.5M | ||
| Q4 24 | $56.9M | $7.1M | ||
| Q3 24 | $74.9M | — | ||
| Q2 24 | $94.5M | $793.0K | ||
| Q1 24 | $112.7M | — |
股东权益ALGSFFAI
| Q4 25 | $53.5M | $-27.3M | ||
| Q3 25 | $71.8M | — | ||
| Q2 25 | $101.9M | — | ||
| Q1 25 | $116.4M | $139.8M | ||
| Q4 24 | $-29.0M | $115.0M | ||
| Q3 24 | $50.1M | — | ||
| Q2 24 | $67.2M | $148.7M | ||
| Q1 24 | $59.8M | — |
总资产ALGSFFAI
| Q4 25 | $88.5M | $277.9M | ||
| Q3 25 | $109.8M | — | ||
| Q2 25 | $134.7M | — | ||
| Q1 25 | $150.7M | $410.6M | ||
| Q4 24 | $70.1M | $425.4M | ||
| Q3 24 | $88.4M | — | ||
| Q2 24 | $108.8M | $457.9M | ||
| Q1 24 | $127.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-82.5M | $-28.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-29.5M |
| 自由现金流率自由现金流/营收 | — | -22886.8% |
| 资本支出强度资本支出/营收 | — | 867.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-91.3M |
8季度趋势，按日历期对齐
经营现金流ALGSFFAI
| Q4 25 | $-82.5M | $-28.4M | ||
| Q3 25 | $-24.3M | — | ||
| Q2 25 | $-15.5M | — | ||
| Q1 25 | $-20.9M | $-20.3M | ||
| Q4 24 | $-18.4M | $-18.4M | ||
| Q3 24 | $-20.1M | — | ||
| Q2 24 | $-19.5M | $-14.4M | ||
| Q1 24 | $-22.7M | — |
自由现金流ALGSFFAI
| Q4 25 | — | $-29.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-21.9M | ||
| Q4 24 | — | $-25.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-14.6M | ||
| Q1 24 | — | — |
自由现金流率ALGSFFAI
| Q4 25 | — | -22886.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -6918.7% | ||
| Q4 24 | — | -10770.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -4993.5% | ||
| Q1 24 | — | — |
资本支出强度ALGSFFAI
| Q4 25 | — | 867.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 496.2% | ||
| Q4 24 | — | 2945.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 88.4% | ||
| Q1 24 | — | — |
现金转化率ALGSFFAI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.85× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
